{
}
Argus has issued "buy" ratings for several pharmaceutical stocks, including Sanofi (SNY) with a $60 price target, Gilead Sciences (GILD) at $85, and GSK at $45. The sector is projected to grow significantly, driven by oncology sales, with companies like Johnson & Johnson and Merck also highlighted for their strong pipelines and dividend yields.
Forbion has successfully raised over $2.2 billion for its latest investment funds, exceeding original targets and bringing total assets under management to over 5 billion euros. The Forbion Growth Opportunities III fund focuses on later-stage biotech companies, while Forbion Ventures VII targets early-stage therapeutics startups. This fundraising follows a series of significant exits, including six investments of at least $1 billion in the past year, enabling Forbion to enhance support for its portfolio companies.
GSK's RSV vaccine, Arexvy, demonstrated 63% overall efficacy and 67% against severe disease over three seasons, though effectiveness declined to 48% in the third season. The CDC currently does not recommend a second dose, but GSK anticipates that revaccination may be necessary to maintain protection. The findings will be presented at the CHEST 2024 Annual Meeting.
GSK plc
Companies
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
pharmaceutical stocks to consider for income and growth potential
Johnson & Johnson
Merck & Co., Inc.
Perrigo Company plc
GSK plc
Sanofi
Amgen Inc.
Gilead Sciences, Inc.
FRA
USA
Jasper Hellweg
Kristina Ruggeri
David Toung
Show more
20:44 15.10.2024
forbion raises over 2 billion dollars for new investment funds
14:10 15.10.2024
GSK RSV vaccine shows effectiveness over three seasons but wanes over time
14:15 08.10.2024
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Industry Mergers & Acquisitions
Finance Mergers & Acquisitions
Domestic Politics
Banking Regulations
Global Financial Events
CEO Changes
Government Policies
Retail and Consumer Goods
Workplace Trends
Elections & Campaigns
Market Analysis and Predictions
Central Bank Actions
Global Trade Developments
Startups & Entrepreneurship
Hedge Funds & Private Equity
Banking & Investment Regulations
Corporate Social Responsibility
Countries:
Companies:
Tesla, Inc.
UniCredit S.p.A.
Banco BPM S.p.A.
Deutsche Bank Money Market PP
JPMorgan Chase & Co.
Barclays PLC
Credit Suisse Strategic Income I
Apple Inc.
CREDIT AGRICOLE
SpaceXCoin USD
Lloyds Banking Group plc
BNP Paribas SA
The Goldman Sachs Group, Inc.
UBS Group AG
Credit Agricole
Banco Santander, S.A.
Amazon.com, Inc.
Reinsurance Group of America, Incorporated
Amundi S.A.
Commerzbank AG
Currencies:
United States Dollar
Euro
British Pound Sterling
Swiss Franc
Chinese Yuan
Indian Rupee
Japanese Yen
South Korean Won
Offshore Chinese Yuan
Hong Kong Dollar
Norwegian Krone
Filipino Peso
Canadian Dollar
Singapore Dollar
Australian Dollar
Danish Krone
Swedish Krona
Mexican Peso
Qatari Riyal
South African Rand
People: